(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.65%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.44%.
Korro Bio's earnings in 2026 is -$106,644,000.On average, 13 Wall Street analysts forecast KRRO's earnings for 2026 to be -$78,309,513, with the lowest KRRO earnings forecast at -$104,625,715, and the highest KRRO earnings forecast at -$65,249,337. On average, 13 Wall Street analysts forecast KRRO's earnings for 2027 to be -$73,339,607, with the lowest KRRO earnings forecast at -$127,715,528, and the highest KRRO earnings forecast at -$54,889,845.
In 2028, KRRO is forecast to generate -$63,887,215 in earnings, with the lowest earnings forecast at -$74,176,024 and the highest earnings forecast at -$48,395,836.